IRIS
REPETTO, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 392
EU - Europa 247
AS - Asia 154
Totale 793
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 392
IE - Irlanda 125
CN - Cina 120
FI - Finlandia 37
UA - Ucraina 31
DE - Germania 29
SG - Singapore 20
IT - Italia 11
GB - Regno Unito 8
IN - India 5
JP - Giappone 4
FR - Francia 3
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HK - Hong Kong 1
TR - Turchia 1
Totale 793
Salva come PNG Salva come JPEG
Città #
Dublin 125
Chandler 118
Jacksonville 41
Boardman 37
Nanjing 29
Ashburn 26
Beijing 21
Helsinki 21
Jiaxing 13
Singapore 13
Lawrence 12
Princeton 12
Medford 11
New York 10
Shanghai 10
Nanchang 9
Hebei 8
Norwalk 8
Shenyang 8
Changsha 6
Los Angeles 6
Hangzhou 5
Tokyo 4
Clifton 3
Dallas 3
Pavia 3
Seattle 3
Cambridge 2
Chicago 2
Houston 2
Hsinchu 2
Kunming 2
Munich 2
Perugia 2
Tianjin 2
Wilmington 2
Woodbridge 2
Ann Arbor 1
Athens 1
Auburn Hills 1
Brno 1
Des Moines 1
Fairfield 1
Falkenstein 1
Hanover 1
Hong Kong 1
Lanzhou 1
Macerata 1
Milan 1
Orange 1
Piscataway 1
Pune 1
Rockville 1
Rome 1
Santa Clara 1
Shaoxing 1
Tappahannock 1
Verona 1
Vienna 1
Zhengzhou 1
Totale 608
Salva come PNG Salva come JPEG
Nome #
Adult-onset type II glycogenosis (GSDII): Clinical spectrum and enzyme replacement therapy (ERT) 78
The angiotensin-converting enzyme insertion/deletion polymorphysm modifies the clinical outcome in patients with Pompe disease. 71
Circulating levels of osteopontin predicts future cardiac events in patients with chronic stable angina 67
Recombinant alpha-glucosidase in adult-onset type II glycogenosis: The experience with the first Italian patient, from expanded access programmes to marketing authorization 66
Early-onset ptosis in type II glycogenosis 60
Clinical governance programme in patients with acute coronary syndrome: Design and methodology of a quality improvement initiative 47
RECOMBINANT ALGLUCOSIDASE ALFA IN ADULT-ONSET GLYCOGENOSIS TYPE II: A FOLLOW-UP STUDY BEFORE AND AFTER TREATMENT 46
Enzyme replacement therapy in adult-onset type II glycogenosis 43
Complex paroxysmal nocturnal behaviors in Parkinson's disease 41
The FLEP scale in diagnosing nocturnal frontal lobe epilepsy, NREM and REM parasomnias: Data from a tertiary sleep and epilepsy unit 38
Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention 38
Adult-onset type II glycogenosis (GSDII): Clinical spectrum and enzyme replacement therapy (ERT) 36
Hallucinations and REM sleep behaviour disorder in Parkinson's disease: Dream imagery intrusions and other hypotheses 35
null 34
REM and NREM sleep enactment behaviors in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies 33
Enzyme replacement therapy in adult-onset glycogenosis II: Is quantitative muscle MRI helpful? 27
Clinical governance of patients with acute coronary syndromes 27
Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful? 26
Totale 813
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.957
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 0 0 0 0 0 6 1 6 0 12 15 0
2020/202157 7 6 0 6 0 10 4 11 0 7 6 0
2021/202247 0 1 0 0 1 0 0 1 4 0 9 31
2022/2023320 25 32 4 19 26 32 0 21 146 3 7 5
2023/2024115 8 27 0 5 9 30 0 7 0 3 5 21
2024/202580 17 21 21 9 12 0 0 0 0 0 0 0
Totale 813